Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Lifshitz Law PLLC Announces Investigations of KTRA, CHX, PIK, and LABP

KTRA, CHX, LABP, PIK

NEW YORK, NY / ACCESSWIRE / April 5, 2024 /

Kintara Therapeutics, Inc. (NASDAQ:KTRA)

Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of KTRA to TuHURA Biosciences, Inc.

If you are a KTRA investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516) 493-9780 or e-mail at info@lifshitzlaw.com.

ChampionX Corporation (NASDAQ:CHX)

Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of CHX and Schlumberger Limited. Under the terms of the agreement, CHX shareholders will receive 0.735 shares of Schlumberger Limited common stock in exchange for each CHX share. At the closing of the transaction, CHX shareholders will own approximately 9% of Schlumberger Limited's outstanding common stock.

If you are a CHX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516) 493-9780 or e-mail at info@lifshitzlaw.com.

Kidpik Corp. (NASDAQ:PIK)

Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of PIK and Nina Footwear Corp. Under the terms of the agreement, Nina Footwear Corp.'s stockholders will own 80% of PIK outstanding common stock.

If you are a PIK investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516) 493-9780 or e-mail at info@lifshitzlaw.com.

Landos Biopharma, Inc. (NASDAQ:LABP)

Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of LABP and AbbVie, Inc. Under the terms of the agreement, AbbVie will acquire Landos at a price of $20.42 per share in cash.

If you are a LABP investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516) 493-9780 or e-mail at info@lifshitzlaw.com.

ATTORNEY ADVERTISING.© 2024 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516) 493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz Law PLLC
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: info@lifshitzlaw.com

SOURCE: Lifshitz Law Firm, P.C.



View the original press release on accesswire.com